The Clorox Company (NYSE:CLX – Get Free Report) has been assigned a consensus recommendation of “Reduce” from the fifteen ratings firms that are currently covering the firm, Marketbeat reports. Four ...
Barclays analyst Lauren Lieberman maintained a Sell rating on Clorox (CLX – Research Report) today and set a price target of $140.00. The ...
CFOs are weighing how much information to share about the impact of tariffs, especially as many are yet to take effect and ...
Barclays analyst Lauren Lieberman maintained a Hold rating on Procter & Gamble (PG – Research Report) today and set a price target of ...
The anti-ESG camp has accumulated high-profile wins lately. In January, a court ruled in favor of an American Airlines pilot ...
All-Star Weekend viewership hits near-record low with 4.7M viewers. Look back at the NBA's biggest event format failures from 2Ball to Dunk Wheel ...
The important thing is that you don’t let a parent company get in the way of your love and appreciation ... distributed products including shampoo and lip balm sold itself to Clorox. It acquired ...
Here's how an activist investor is threatening a Peninsula drug maker's merger plans. And the drama introduces a potential ...
Chemical engineers have discovered that adding nickel atoms to silver catalysts could revolutionize the production of ethylene oxide by eliminating the need for toxic chlorine while maintaining ...
Doctors harvest stem cells from the patient’s bone marrow and then send them off to a lab, where CRISPR is used to turn up the production of another, functional version of haemoglobin. This version is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results